SASKATOON, Saskatchewan--(BUSINESS WIRE)--Brent Zettl, the President and CEO of ZYUS Life Sciences Inc. (“ZYUS”), received the Startup Canada Entrepreneur of the Year Award for the Prairies region in Edmonton, Alberta sponsored by Scotiabank. As a proud winner of the sixth annual Startup Canada Awards, ZYUS is thrilled to help celebrate outstanding achievement in Canada’s entrepreneurship and innovation community across Canada.
“While many think of an entrepreneur as a person, this award is not about an individual, it’s about a team – an amazing group of dedicated and talented people who are passionate, energetic and share a deep entrepreneurial spirit,” said Brent Zettl, President and CEO of ZYUS. “Together, we intend on caring for the overall well-being of patients by focusing on accelerating adoption of cannabinoids as a medical solution.”
"I’m truly honored to have been recognized by Startup Canada for the Prairie Regional Entrepreneur of Year Award,” continued Zettl. “While it is a very exciting time for the cannabis sector not just in Canada, but increasingly on a global scale, ZYUS is focused from a biopharmaceutical perspective on bringing a purpose to the development and application of cannabinoids and other phyto-therapeutic medical solutions for the betterment of humankind.”
Regional winners will now be evaluated by the National Adjudication Committee; comprised of some of Canada’s leading entrepreneurship and industry experts. The national winners will be announced and celebrated at the Startup Canada Awards Grand Finale in Toronto in October, 2019.
“Congratulations to the 2019 winners of the Startup Canada Awards,” said Victoria Lennox, Co-Founder and President of Startup Canada. “Each and every one of these outstanding recipients has an immense impact on the future of Canada and they all represent the greatness and diversity of our nation’s entrepreneurship community. We are proud to celebrate excellence and impact across Canada by recognizing the entrepreneurs, innovators and support ecosystem making it happen.”
About the Startup Canada Awards:
The Startup Canada Awards can be likened to the Oscars for the Canadian entrepreneurship community. The awards celebrate and recognize individuals, communities, and institutions that demonstrate innovation, excellence, outstanding achievement, and impact in advancing entrepreneurship in Canada:
- Celebrate those working to advance entrepreneurship in Canada;
- Increase awareness of the importance of strengthening Canada’s entrepreneurship ecosystem and culture; and,
- Incentivize efforts and elevate the ambitions of the Canadian entrepreneurial and innovation community.
About ZYUS Life Sciences Inc.:
ZYUS is a Canadian-based life sciences company focused on the global development and commercialization of innovative and value-added cannabinoid-based therapeutics. Through clinical research and IP development, we intend on delivering high-quality oils, gel-caps, topical creams and other therapeutic formulations to patients worldwide.
At ZYUS, our vision is to elevate cannabinoids as a standard of care to reimagine the potential of medicine and responsibly disrupt the biopharmaceutical industry.
ZYUS: Advancing the Science of Well-Being. For more information, please visit www.ZYUS.com
About Startup Canada:
Startup Canada is the national rallying community and voice for Canada’s 2.3 million entrepreneurs. Since launching in 2012, Startup Canada has grown to represent more than 200,000 entrepreneurs and 50 grassroots communities from coast to coast to coast. Through digital programs and flagship events, Startup Canada is the network promoting, inspiring, educating, connecting and giving a voice to Canada’s entrepreneurs; supporting them to start, operate and scale businesses that build a better Canada for the world today and for future generations. For more information, visit www.startupcan.ca.
This news release contains forward-looking statements. Forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of ZYUS to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. These forward-looking statements include, but are not limited to expectations with respect to our business plans and product lines.
Often, but not always, forward-looking statements can be identified by the use of words such as “plans”, “expects” or “does not expect”, “is expected”, “estimates”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved. Forward-looking statements are based on certain assumptions and are subject to various known and unknown risks and uncertainties, many of which are beyond the Company’s control, and cannot be predicted or quantified and consequently, actual results may differ materially from those expressed or implied by such forward-looking statements.
Accordingly, readers should not place undue reliance on the forward-looking statements and information contained in this press release. Since forward-looking statements and information address future events and conditions, by their very nature they involve inherent risks and uncertainties.
Actual results could differ materially from those currently anticipated due to a number of factors and risks. Readers are cautioned that the foregoing list of factors is not exhaustive. The forward-looking statements contained in this news release are made as of the date of this release and, accordingly, are subject to change after such date. ZYUS does not assume any obligation to update or revise any forward-looking statements, whether written or oral, that may be made from time to time by us or on our behalf, except as required by applicable law.